Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF

British Journal of Ophthalmology

Volumn 91, Issue 12, 2007, Pages 1607-1609

  O'Hearn, Thomas M ^a   Fawzi, Amani ^a   He, Shikun ^a   Rao, Narsing A ^a   Lim, Jennifer I ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AMYLOID NEUROPATHY; AMYLOIDOSIS; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HUMAN; INTRAOCULAR PRESSURE; LIVER TRANSPLANTATION; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; SEQUENCE ANALYSIS; SLIT LAMP; VISUAL ACUITY; VITRECTOMY; VITREOUS DISEASE;

ADULT; AGE OF ONSET; AMYLOID NEUROPATHIES, FAMILIAL; ASIAN CONTINENTAL ANCESTRY GROUP; EYE DISEASES, HEREDITARY; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; GLUTAMIC ACID; GLYCINE; HUMANS; MALE; MUTATION; PREALBUMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRECTOMY; VITREOUS BODY;

EID: 36749045270     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.119495     Document Type: Article

References (11)

1. Saraiva MJ. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat 2001;17:493-503.
2. Kawaji T, Ando Y, Nakamura M, et al. Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C. Ophthalmology 2005;112:2212.
3. Brett M, Persey MR, Reilly MM, et al. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 1999;122:183-90.
4. Ando E, Ando Y, Okamura R, et al. Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up. Br J Ophthalmol 1997;81:295-8.
5. Dun EJ, Yang HS, Haller JA, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 2004;137:668-74.
6. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006;244:309-15.
7. Kim HS, Kim SM, Kang SW, et al. An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene. Eur J Neurol 2005;12:657-9.
8. Reilly MM, Adams D, Booth DR, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118:849-56.
9. Fitch NJ, Akbari MT, Ramsden DB. An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing. J Endocrinol 1991;129:309-13.
10. Ando E, Ando Y, Haraoka K. Ocular amyloid involvement after liver transplantation for polyneuropathy. Ann Intern Med 2001;135:931-2.
11. Ando Y, Terazaki H, Nakamura M, et al. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 2004;77:345-9.